BioSpace News Archive

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510-cleared device platform indicated to reduce blood culture contamination,1 announced continued clinical efficacy data supporting multiple, peer-reviewed clinical studies that confirm zero or near-zero false-positive rates from blood cultures drawn from peripheral intravenous starts.

Predictive Health Diagnostics Company, Inc. (“PHDC” or “the Company”), today announced a new milestone with placement of the 120,000th order of the PULS Cardiac Test™

U.S. Renal Care, a leading provider of dialysis services, announced it has completed administering the second round of mRNA vaccines to patients, ensuring better protection against the deadly coronavirus for thousands of vulnerable patients on dialysis.

Histogen Inc. announced the closing of its previously announced registered direct offering for the issuance and sale of 5,977,300 shares of its common stock, at a purchase price of $1.10 per share, in a registered direct offering priced at-the-market under Nasdaq rules.

DNAtrix, today announced that the company will present at the Raymond James Human Health Innovations Conference on Monday, June 21, 2021 , at 1:20 pm ET .

Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted ten new employees options to purchase a total of 115,800 shares of the Company’s common stock at an exercise price per share of $24.76, which was the closing price on June 8, 2021.

MediWound Ltd. (Nasdaq: MDWD), today announced that the enrollment target of patients for an interim assessment of its EscharEx® U.S. phase 2 adaptive design study for the treatment of venous leg ulcers (VLUs) has been achieved, and interim assessment is expected by the end of July 2021.

Gravity Diagnostics has partnered with the Commonwealth of Kentucky to provide a COVID-19 testing drive-thru located at 302 W 4th St Parking in Covington, Kentucky.

CTI BioPharma Corp. announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees as equity inducement awards outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

Centogene N.V. today announced that it will issue its financial results for the quarter ended March 31, 2021, on Wednesday, June 16, 2021.